Viral Hepatitis Updates from CDC - USPSTF Draft Recommendation Statement on Screening for Hepatitis B Virus InfectionCenters for Disease Control and Prevention (CDC) sent this bulletin at 02/20/2014 08:56 AM EST
Viral Hepatitis Updates from CDC
Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: U.S. Preventive Services Task Force DRAFT Recommendation Statement
The U.S. Preventive Services Task Force recently posted a draft Evidence Report and draft Recommendation Statement on screening for hepatitis B virus infection in nonpregnant adolescents and adults. Both are available for review and public comment through March 10, 2014. To review the draft Evidence Report and draft Recommendation Statement and submit comments, go tohttp://www.uspreventiveservicestaskforce.org/tfcomment.htm.
AASLD/IDSA Recommendations for Testing, Managing, and Treating Hepatitis CNew direct-acting oral agents capable of curing hepatitis C virus (HCV) infection have been approved for use in the United States. The initial direct-acting agents were approved in 2011, and many more oral drugs are expected to be approved in the next few years. As new information is presented at scientific conferences and published in peer-reviewed journals, health care practitioners have expressed a need for a credible source of unbiased guidance on how best to treat their patients with HCV infection. To provide healthcare professionals with timely guidance, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) in collaboration with the International Antiviral Society-USA (IAS-USA) have developed a web-based process for the rapid formulation and dissemination of evidence-based, expert-developed recommendations for hepatitis C management. http://hcvguidelines.org/